Understanding how T cells adapt to fight solid tumors
Discovering T cell proteome turnover dynamics to overcome the solid tumor microenvironment
This study is looking at how T cells change their proteins to better fight solid tumors, with the goal of making treatments more effective for patients battling cancer.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of Arkansas for Med Scis NIH-funded |
| Lab location | 1 site (Little Rock, United States) |
| Project ID | NIH-10918308 on NIH RePORTER |
What this research studies
This research investigates the dynamics of T cell proteome turnover to enhance the effectiveness of cellular therapies against solid tumors. By analyzing how T cells prepare for stress and adapt their protein composition, the study aims to identify key proteins that enable T cells to overcome the challenges posed by the complex biology of solid tumors. The approach combines multiple techniques, including proteome and transcriptome analysis, to gain insights into T cell behavior in response to the tumor microenvironment.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients with solid tumors who may benefit from advanced T cell therapies.
Not a fit: Patients with hematologic cancers may not benefit directly from this research, as it focuses on solid tumors.
Why it matters
Potential benefit: If successful, this research could lead to more effective cancer treatments by improving the performance of T cell therapies against solid tumors.
How similar studies have performed: While the approach of analyzing T cell proteome dynamics is innovative, similar studies in the field of cancer immunotherapy have shown promise in enhancing treatment efficacy.
Where this research is happening
Little Rock, United States
- Univ of Arkansas for Med Scis — Little Rock, United States (Active)
Researchers
- Principal investigator: Koss, Brian — Univ of Arkansas for Med Scis
- Study coordinator: Koss, Brian
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.